BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11801316)

  • 1. Does trisomy 7 occur in a particular cell type in the thyroid?
    Cortezzi SS; César AC; Tajara EH; Suzigan S; Góis Filho JF; Fukuyama EE; Ribeiro PR
    Cancer Genet Cytogenet; 2002 Jan; 132(1):77-8. PubMed ID: 11801316
    [No Abstract]   [Full Text] [Related]  

  • 2. Significance of trisomy 7 and 12 in thyroid lesions with follicular differentiation: a cytogenetic and in situ hybridization study.
    Roque L; Serpa A; Clode A; Castedo S; Soares J
    Lab Invest; 1999 Apr; 79(4):369-78. PubMed ID: 10211989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interphase cytogenetic analysis of normal tissue of thyroid gland by fluorescence in situ hybridization.
    Barril N; Carvalho-Sales AB; Tajara EH
    Cancer Genet Cytogenet; 1999 Oct; 114(2):162-4. PubMed ID: 10549277
    [No Abstract]   [Full Text] [Related]  

  • 4. Trisomy 17 as a marker for a subset of noninvasive thyroid nodules with focal features of papillary carcinoma: cytogenetic and molecular analysis of 62 cases and correlation with histological findings.
    Frau DV; Lai ML; Caria P; Dettori T; Coni P; Faa G; Morandi L; Tallini G; Vanni R
    J Clin Endocrinol Metab; 2008 Jan; 93(1):177-81. PubMed ID: 17956956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Karyotypic characterization of papillary thyroid carcinomas.
    Roque L; Nunes VM; Ribeiro C; Martins C; Soares J
    Cancer; 2001 Nov; 92(10):2529-38. PubMed ID: 11745186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Balanced translocation (3;7)(p25;q34): another mechanism of tumorigenesis in follicular thyroid carcinoma?
    Lui WO; Kytölä S; Anfalk L; Larsson C; Farnebo LO
    Cancer Genet Cytogenet; 2000 Jun; 119(2):109-12. PubMed ID: 10867144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aneuploidy in oncocytic lesions of the thyroid gland: diffuse accumulation of mitochondria within the cell is associated with trisomy 7 and progressive numerical chromosomal alterations.
    Dettori T; Frau DV; Lai ML; Mariotti S; Uccheddu A; Daniele GM; Tallini G; Faa G; Vanni R
    Genes Chromosomes Cancer; 2003 Sep; 38(1):22-31. PubMed ID: 12874783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA copy number changes in thyroid carcinoma.
    Hemmer S; Wasenius VM; Knuutila S; Franssila K; Joensuu H
    Am J Pathol; 1999 May; 154(5):1539-47. PubMed ID: 10329606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Loss of heterozygosity on chromosome 3p in thyroid tumors].
    Hu MJ; Xu HD; Zhou R; Li XF; Zhang HY
    Zhonghua Bing Li Xue Za Zhi; 2008 May; 37(5):305-8. PubMed ID: 18956647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of trisomy 7 in thyroid tumors.
    Herrmann ME; Lalley PA
    Cancer Genet Cytogenet; 1992 Sep; 62(2):144-9. PubMed ID: 1394100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal trisomies 7,10 and 12, normal 3p and absence of VHL gene mutation in a clear cell tubulopapillary carcinoma of the kidney.
    Wolfe A; Dobin SM; Grossmann P; Michal M; Donner LR
    Virchows Arch; 2011 Oct; 459(4):457-63. PubMed ID: 21822960
    [No Abstract]   [Full Text] [Related]  

  • 12. From amplification to gene in thyroid cancer: a high-resolution mapped bacterial-artificial-chromosome resource for cancer chromosome aberrations guides gene discovery after comparative genome hybridization.
    Chen X; Knauf JA; Gonsky R; Wang M; Lai EH; Chissoe S; Fagin JA; Korenberg JR
    Am J Hum Genet; 1998 Aug; 63(2):625-37. PubMed ID: 9683604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene Fusions in Thyroid Cancer.
    Yakushina VD; Lerner LV; Lavrov AV
    Thyroid; 2018 Feb; 28(2):158-167. PubMed ID: 29281951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetic findings in 31 papillary thyroid carcinomas.
    Roque L; Clode AL; Gomes P; Rosa-Santos J; Soares J; Castedo S
    Genes Chromosomes Cancer; 1995 Jul; 13(3):157-62. PubMed ID: 7669734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interphase fluorescence in situ hybridization analysis detects a much higher rate of thyroid tumors with clonal cytogenetic deviations of the main cytogenetic subgroups than conventional cytogenetics.
    Drieschner N; Rippe V; Laabs A; Dittberner L; Nimzyk R; Junker K; Rommel B; Kiefer Y; Belge G; Bullerdiek J; Sendt W
    Cancer Genet; 2011 Jul; 204(7):366-74. PubMed ID: 21872823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma.
    Melillo RM; Cirafici AM; De Falco V; Bellantoni M; Chiappetta G; Fusco A; Carlomagno F; Picascia A; Tramontano D; Tallini G; Santoro M
    Am J Pathol; 2004 Aug; 165(2):511-21. PubMed ID: 15277225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [From the cytogenetics to the cytogenomics of thyroid tumors].
    Perissel B; Bernheim A; Couturier J; Fouilhoux G; Vago P
    Bull Cancer; 2002 Jun; 89(6):588-92. PubMed ID: 12135859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Numerical chromosomal aberrations in thyroid tumors detected by double fluorescence in situ hybridization.
    Taruscio D; Carcangiu ML; Ried T; Ward DC
    Genes Chromosomes Cancer; 1994 Mar; 9(3):180-5. PubMed ID: 7515660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid carcinoma: diagnostic and therapeutic approach; genetic background (review).
    Lewinski A; Ferenc T; Sporny S; Jarzab B
    Endocr Regul; 2000 Jun; 34(2):99-113. PubMed ID: 10991553
    [No Abstract]   [Full Text] [Related]  

  • 20. RET rearrangements in papillary thyroid carcinomas and adenomas detected by interphase FISH.
    Cinti R; Yin L; Ilc K; Berger N; Basolo F; Cuccato S; Giannini R; Torre G; Miccoli P; Amati P; Romeo G; Corvi R
    Cytogenet Cell Genet; 2000; 88(1-2):56-61. PubMed ID: 10773666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.